This video summarizes the rationale for and controversies surrounding recommendations made by the Clinical Guidelines Committee of the American College of Physicians (ACP) in its 2018 Guidance Statement on hemoglobin A1c (HbA1c) targets for glycemic control with pharmacology therapy for nonpregnant adults with type 2 diabetes. Elizabeth L. Tung, MD, MS, and Neda Laiteerapong, MD, MS, both of the Chicago Center for Diabetes Translation Research in the Section of General Internal Medicine at the University of Chicago, explain.

Listen to the podcast:
Read the JAMA Medical News & Perspectives article:
Read the JAMA Clinical Guidelines Synopsis: